We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Soliris Recall Could Cost Alexion $25 Million to Fix
Soliris Recall Could Cost Alexion $25 Million to Fix
November 18, 2013
Alexion’s recall and replacement of vials of its rare disease drug Soliris could cost the company between $10 and $25 million in the fourth quarter, the drugmaker said in a Nov. 12 SEC filing.